In July, The Lancet Psychiatry published a commentary attacking Peter Gotzsche and the Council for Evidence-based Psychiatry, suggesting their criticism of the lack of effectiveness of psychiatric drugs, and particularly of antidepressants, is “extreme” and “insulting” and “plumbs a new nadir in irrational polemic.” Leaders of the Council for Evidence-based Psychiatry respond in the same journal this month, writing that they are “tired of the intellectual malaise, corruption, and indifference” in some psychiatrists and “deeply concerned about the potentially devastating impact this blindness is having on the lives of millions of people who have been on the receiving end of a pharmaceutical revolution borne out of good marketing manipulating poor science.”
Both letters are available in full online.
Antipsychiatry and the antidepressants debate (Timimi, Sami et al. The Lancet Psychiatry, Volume 1, Issue 3, Page 174, August 2014. doi:10.1016/S0140-6736(08)61345-8)
Attacks on antidepressants: signs of deep-seated stigma? (Nutt DJ et al. The Lancet Psychiatry, Volume 1, Issue 2, Pages 102 – 104, July 2014. doi:10.1016/S2215-0366(14)70232-9) Full text available here.